Unilever PLC (LSE:ULVR) notes recent reporting regarding its interest in GlaxoSmithKline plc (LSE:GSK)'s Consumer Healthcare and confirms that it has approached GSK and Pfizer Inc. (NYSE:PFE) about a potential acquisition of the business. GSK Consumer Healthcare is a leader in the attractive consumer health space and would be a strong strategic fit as Unilever continues to re-shape its portfolio. There can be no certainty that any agreement will be reached.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.98 USD | +0.65% |
|
+0.87% | -2.81% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
4,345 GBX | -0.73% | -2.01% | 137B | ||
1,530 GBX | +0.23% | -4.35% | 78.83B | ||
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.81% | 159B | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Unilever Reports Interest in Acquiring GSK Consumer Healthcare